These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6139573)

  • 21. Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer.
    Ekman R; Larsson I; Malmquist M; Thorell JI
    Regul Pept; 1983 Aug; 6(4):371-8. PubMed ID: 6688882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia.
    Sulkava R; Erkinjuntti T; Laatikainen T
    Neurology; 1985 Jul; 35(7):1057-8. PubMed ID: 3159972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.
    Poduslo JF; Curran GL; Kumar A; Frangione B; Soto C
    J Neurobiol; 1999 Jun; 39(3):371-82. PubMed ID: 10363910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The degradation of a nonapeptide, sleep inducing peptide, in rat brain: comparison with enkephalin breakdown.
    Huang JT; Lajtha A
    Res Commun Chem Pathol Pharmacol; 1978 Feb; 19(2):191-9. PubMed ID: 25463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary aluminum and Alzheimer's disease--a review.
    Caster WO; Wang M
    Sci Total Environ; 1981 Jan; 17(1):31-6. PubMed ID: 7010599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aluminum induced reversible change in permeability of the blood-brain barrier to [14C]sucrose.
    Kim YS; Lee MH; Wisniewski HM
    Brain Res; 1986 Jul; 377(2):286-91. PubMed ID: 3730864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma levels of opioid peptides and delta sleep-inducing peptide but not of corticotropin-releasing hormone in patients receiving chronic hemodialysis.
    Hegbrant J; Thysell H; Ekman R
    Blood Purif; 1991; 9(4):188-94. PubMed ID: 1667974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier permeability of novel [D-arg2]dermorphin (1-4) analogs: transport property is related to the slow onset of antinociceptive activity in the central nervous system.
    Deguchi Y; Naito Y; Ohtsuki S; Miyakawa Y; Morimoto K; Hosoya K; Sakurada S; Terasaki T
    J Pharmacol Exp Ther; 2004 Jul; 310(1):177-84. PubMed ID: 15031301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Aluminum and Alzheimer's disease].
    Belojević G; Jakovljević B
    Srp Arh Celok Lek; 1998; 126(7-8):283-9. PubMed ID: 9863396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endogenous peptides in the organization of somato-vegetative responses to hypothalamic stimulation].
    Badikov VI; Burchuladze RA; Gabuniia AE; Kashmanov SI; Fedianina NG
    Fiziol Zh SSSR Im I M Sechenova; 1985 Jul; 71(7):840-7. PubMed ID: 2412900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d-enantiomeric peptide.
    Jiang N; Frenzel D; Schartmann E; van Groen T; Kadish I; Shah NJ; Langen KJ; Willbold D; Willuweit A
    Biochim Biophys Acta; 2016 Nov; 1858(11):2717-2724. PubMed ID: 27423267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of 125I-Tyr27 beta-endorphin for the study of beta-endorphin binding sites in rat cortex.
    Toogood CL; McFarthing KG; Hulme EC; Smyth DG
    Neuroendocrinology; 1986; 43(6):629-34. PubMed ID: 3020464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability.
    Banks WA; Kastin AJ
    Brain Res Bull; 1985 Sep; 15(3):287-92. PubMed ID: 2413968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport of the synthetic peptide DSIP through the blood-brain barrier in rabbit.
    Monnier M; Dudler L; Gächter R; Schoenenberger GA
    Experientia; 1977 Dec; 33(12):1609-10. PubMed ID: 590449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of CRH from mouse brain directly affects peripheral production of beta-endorphin by the spleen.
    Martins JM; Banks WA; Kastin AJ
    Am J Physiol; 1997 Dec; 273(6):E1083-9. PubMed ID: 9435522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication.
    Deloncle R; Guillard O
    Neurochem Res; 1990 Dec; 15(12):1239-45. PubMed ID: 1982955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.
    Heilig M; Sjögren M; Blennow K; Ekman R; Wallin A
    Biol Psychiatry; 1995 Aug; 38(4):210-6. PubMed ID: 8547442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP).
    Schoenenberger GA
    Eur Neurol; 1984; 23(5):321-45. PubMed ID: 6548966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aluminum transfer as glutamate complex through blood-brain barrier. Possible implication in dialysis encephalopathy.
    Deloncle R; Guillard O; Clanet F; Courtois P; Piriou A
    Biol Trace Elem Res; 1990 Apr; 25(1):39-45. PubMed ID: 1696110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.